Your browser doesn't support javascript.
loading
BCR kinase inhibitors, idelalisib and ibrutinib, are active and effective in Richter syndrome.
Visentin, Andrea; Imbergamo, Silvia; Scomazzon, Edoardo; Pravato, Stefano; Frezzato, Federica; Bonaldi, Laura; Pizzi, Marco; Vio, Stefania; Gregianin, Michele; Burei, Marta; Facco, Monica; Semenzato, Gianpietro; Piazza, Francesco; Trentin, Livio.
Afiliación
  • Visentin A; Haematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padua, Italy.
  • Imbergamo S; Venetian Institute of Molecular Medicine, Centro di Eccellenza per la Ricerca Biomedica Avanzata, Padua, Italy.
  • Scomazzon E; Haematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padua, Italy.
  • Pravato S; Haematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padua, Italy.
  • Frezzato F; Haematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padua, Italy.
  • Bonaldi L; Haematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padua, Italy.
  • Pizzi M; Venetian Institute of Molecular Medicine, Centro di Eccellenza per la Ricerca Biomedica Avanzata, Padua, Italy.
  • Vio S; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCSS, Padua, Italy.
  • Gregianin M; General Pathology & Cytopathology Unit, Department of Medicine, University of Padua, Padua, Italy.
  • Burei M; Radiology Unit, University Hospital of Padua, Padua, Italy.
  • Facco M; Nuclear Medicine unit, San Giacomo Hospital, Castelfranco Veneto, Italy.
  • Semenzato G; Nuclear Medicine unit, Veneto Institute of Oncology IOV-IRCSS, Padua, Italy.
  • Piazza F; Haematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padua, Italy.
  • Trentin L; Venetian Institute of Molecular Medicine, Centro di Eccellenza per la Ricerca Biomedica Avanzata, Padua, Italy.
Br J Haematol ; 185(1): 193-197, 2019 04.
Article en En | MEDLINE | ID: mdl-29974955

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica Límite: Humans Idioma: En Revista: Br J Haematol Año: 2019 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica Límite: Humans Idioma: En Revista: Br J Haematol Año: 2019 Tipo del documento: Article País de afiliación: Italia